Sickle-cell anaemia is an autosomal recessive disorder characterized by the production of an abnormal form of hemoglobin, known as HbS. This condition is particularly prevalent among individuals of African descent, providing some protection against malaria for those who are carriers.
| 🔬 Concept | ⚡ Key Point | 🌍 Application |
|---|---|---|
| Sickle-Cell Anaemia | Autosomal recessive condition | Common in individuals of African descent |
| HbS | Abnormal hemoglobin | Causes red blood cell sickling |
| HbF | Fetal hemoglobin | Protective in sickle-cell disease |
🧪 Core Principles
Sickle-cell anaemia results from a mutation in the beta-globin gene on chromosome 11.
The condition manifests in various forms:
- Normal hemoglobin: HbAA
- Sickle cell trait: HbAS
- Homozygous sickle cell disease: HbSS
- HbSC disease: Inheritance of HbS and HbC, leading to milder symptoms.
The substitution of the polar amino acid glutamate with the non-polar valine at codon 6 causes decreased solubility of deoxy-Hb. This polymerization under low oxygen conditions leads to sickling of red blood cells (RBCs).
⚗️ Process
The symptoms of sickle-cell anaemia typically appear between 4-6 months of age, as fetal hemoglobin is gradually replaced by HbSS.
Key points about sickling include:
- HbAS patients begin sickling at pO2 2.5 - 4 kPa.
- HbSS patients sickle at pO2 5 - 6 kPa.
- The sickled RBCs are fragile, leading to hemolysis and blockage of small blood vessels, resulting in infarctions.
🌍 Applications
The definitive diagnosis of sickle cell disease is made through hemoglobin electrophoresis.
Management strategies include:
Crisis Management:
- Analgesia (e.g., opiates)
- Rehydration
- Oxygen therapy
- Consideration of antibiotics if infection is suspected
- Blood transfusion for severe cases
- Exchange transfusion for neurological complications
Long-term Management:
- Hydroxyurea to increase HbF levels and prevent painful episodes
- Pneumococcal polysaccharide vaccine every 5 years for patients
📝 Key Takeaways
- Sickle-cell anaemia is caused by a mutation leading to abnormal hemoglobin, primarily affecting individuals of African descent.
- The disease is characterized by painful crises and a variety of complications, necessitating careful management.
🚀 Learning Boosters
💡 Key Insight: The substitution of glutamate with valine in hemoglobin leads to sickling, causing significant health issues.
🌍 Real-World: Understanding sickle-cell anaemia is vital for effective treatment and prevention strategies in affected populations.
⚠️ Common Pitfall: Rapidly reducing the percentage of HbS-containing cells during exchange transfusions can lead to complications.